Blood Gas Sampling
Deviceanalyzing amniotic fluid by blood gas device
NCT Number: NCT02813954
Amniotic fluid (AF) is a complex structure with a changing content by gestational time. AF pH can be affected by both maternal and fetal conditions such as preterm ruptures of membranes, prematurity and fetal distress. While fetal urine is the major content of AF since 20th gestational week, fetal lung liquid (FLL) also acts as a minor content. Secretion of FLL depends on chloride transport and postnatal clearance of FLL is provided by active reabsorption of sodium (Na) ions. Down-regulation of epithelial Na channels (ENaCs) and an increase of pulmonary compliance accompany to pulmonary adaptation developing at the first hours of life. Lower genomic expression of Na channels in airways is shown to be associated to respiratory distress syndrome (RDS) in preterm. Although pH and electrolyte value of AF is thought to be relevant to fetal and maternal conditions such as gestational age, antenatal steroids and preterm birth, there is no study about this topic in the literature.
Looking for future studies?
Notify MeUp to 25 hour
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Accepted to participate with informed consent Normal healthy pregnancies
Exclusion criteria
Congenital abnormalities Chromosomal abnormalities Blood contaminated AF Declined to participate
analyzing amniotic fluid by blood gas device
Time frame: 8 months
Kanuni Sultan Suleyman Training and Research Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01517958
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
New York, United States
View Trial DetailsNCT05987800
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Jette, Brussels Capital, Belgium
View Trial DetailsNCT06992492
Lung Diseases, Respiration Disorders
Banī Suwayf, Egypt
View Trial DetailsNCT06168149
Female Urogenital Diseases and Pregnancy Complications, Lung Diseases
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial Details